about
Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependenceThe effect of cannabis compared with alcohol on drivingThe waterpipe: a new way of hooking youth on tobaccoAntiretroviral medication: an emerging category of prescription drug misuseGenome-wide association discoveries of alcohol dependenceAuricular acupuncture as an adjunctive treatment for cocaine addiction. A pilot studyCocaine-induced mood disorder: prevalence rates and psychiatric symptoms in an outpatient cocaine-dependent sampleGender differences in treatment-seeking cocaine abusers--implications for treatment and prognosisAn association between genetic variation in the glutamatergic system and suicide attempts in alcohol-dependent individuals.(Invited review) genetic research on alcohol use outcomes in African American populations: A review of the literature, associated challenges, and implications.A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.Feasibility of matching alcohol patients to ASAM levels of care.Somatization, anxiety and depression in a drug-free residential therapeutic community.Barriers to the use of medications to treat alcoholism.Examining potential school contextual influences on gambling among high school youth.Methamphetamine-using felons: psychosocial and behavioral characteristics.Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexoneEffect of alcohol references in music on alcohol consumption in public drinking places.Dextromethorphan and quinidine combination for heroin detoxification.Improving temporal efficiency of outpatient buprenorphine induction.Recovery rates after treatment for alcohol/drug dependence. Tobacco users vs. non-tobacco users."Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence.Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.A two-rate hypothesis for patterns of retention in psychosocial treatments of cocaine dependence: findings from a study of African-American men and a review of the published data.Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.Problem drinking by race and nativity: what is learned from social structural and mental health-related data of US-born and immigrant respondents?Trauma exposure predicts alcohol, nicotine, and drug problems beyond the contribution of PTSD and depression in patients with cardiovascular disease: data from the Heart and Soul StudyPsychosocial correlates of alcohol use and heavy episodic drinking among Italian adolescents: Data from the second International Self-Reported Delinquency study.Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India.Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants.Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexone.Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review.Stimulant psychosis: symptom profile and acute clinical course.Cognitive impairment in individuals currently using methamphetamine.Neural activity related to anger in cocaine-dependent men: a possible link to violence and relapse.Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration.The inclusion of women and minorities in smoking cessation clinical trials: a systematic review.Attitudes toward buprenorphine and methadone among opioid-dependent individuals.
P1433
Q24645054-292E99E4-9BB0-4CEE-AC7C-9458CB5F70F5Q24655212-B916697F-88BA-4F66-81A8-8C09B6FE8538Q26852412-BC039ABB-7D3B-4714-8571-6DF046F9AE25Q26852974-E8ABA425-C352-47CE-A267-85458DBCA466Q27003168-4B3F79FD-05EB-4FEC-8F00-3071E44B9B84Q28271472-50F8154A-7C29-4210-9997-27BB47F82EE5Q28377607-1BAC1DEB-133E-434D-A276-C19292054ADEQ28377630-0C4B82B8-7F05-422A-A1EE-BF42BED9241EQ30101002-B7A2CAA1-C65F-4C54-9BFB-31F015DA9DE8Q30235548-7FA59A5D-10C9-4CC4-BB3D-2462D0BA70E5Q30239840-3C8F8D3B-A1F5-4F18-A8D1-EAAF167C953FQ30330362-FEB11454-741C-4444-B700-B8FEB9CFCDC1Q30332587-BB4C8EEA-0A77-4376-BC1D-964BCB61D7CAQ30335778-88DD1FBB-CC41-4900-8DF6-3891885B228CQ30360808-FA497885-FD8C-4339-AEE8-F5C08A55AB15Q30367290-2A5A7817-0175-453A-B313-89A664984FD0Q30399592-94D3ABF5-81E1-4DDD-A64A-FB8A5759F433Q30408161-23031E91-764F-4F7F-A2AF-3837CE1BAE1BQ30418597-F7F91B61-0DA7-4CF1-8A3F-31908FBE5358Q30425074-0DC3AD80-8EFA-46DC-B1BA-AE5D10E7BE37Q30427149-2F91A625-C719-4F0D-BBD7-2E1D56A8C7F4Q30455650-C9051130-83F6-48EB-9BF4-5F40A63E8E6DQ30463995-B0EB2D35-261A-4B07-B077-368E520DBFC0Q30524334-0CC73270-960C-4943-A6D6-BD9EE30EC281Q30576095-43B2EA6E-2168-4F2E-92E1-CAE9565F6063Q30585461-4C8DF33A-C7B0-43BE-9BCD-53028645C816Q30619876-6AFC2892-93C9-4628-BF57-3E61C1CA31D1Q30650553-F8D2FAAB-75A6-4B78-B994-9D46313EDAB9Q30710072-824B77AD-B3DB-4F1D-AA7E-38E85B8B8BA5Q30989805-C50AA1F4-2E52-4323-A1D4-2524F0B2F875Q31007528-7FBD398A-D335-4C5F-B80F-1092DF92B7C1Q31036087-8C9C2BD1-57EF-4F0F-B26E-DE8A91006498Q31131823-667D907C-7805-4C00-B4D3-29B4A6829F6DQ31155590-674BB6CF-DD57-422A-8ECC-9BD967D8EB07Q31416884-7BB307E6-FD39-4B82-9BC8-654D7EDD564BQ31440547-49A79544-079C-496C-A0CC-520368F2F153Q31825162-7091C8C8-4C6C-41AA-A7F1-5C722711CB98Q33387266-E1D91B50-C5BB-4B88-954B-3B57DC107E30Q33409572-3C2B35B4-BDC2-46DB-BEFD-000E2EE7200EQ33621921-6D61F290-472E-4DDA-9DD4-52B29E519587
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Wiley-Blackwell
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
American Journal on Addictions
@ast
American Journal on Addictions
@da
American Journal on Addictions
@en
American Journal on Addictions
@es
American Journal on Addictions
@fi
American Journal on Addictions
@fr
American Journal on Addictions
@it
American Journal on Addictions
@nb
American Journal on Addictions
@nl
American Journal on Addictions
@nn
type
label
American Journal on Addictions
@ast
American Journal on Addictions
@da
American Journal on Addictions
@en
American Journal on Addictions
@es
American Journal on Addictions
@fi
American Journal on Addictions
@fr
American Journal on Addictions
@it
American Journal on Addictions
@nb
American Journal on Addictions
@nl
American Journal on Addictions
@nn
prefLabel
American Journal on Addictions
@ast
American Journal on Addictions
@da
American Journal on Addictions
@en
American Journal on Addictions
@es
American Journal on Addictions
@fi
American Journal on Addictions
@fr
American Journal on Addictions
@it
American Journal on Addictions
@nb
American Journal on Addictions
@nl
American Journal on Addictions
@nn
P31
P3181
P356
P1055
P1058
P1156
P123
P1277
P1476
American Journal on Addictions
@en
P236
P356
10.1111/(ISSN)1521-0391